Autonomy versus protection - who benefits from the regulation of IVF?

被引:8
|
作者
English, Veronica [1 ]
机构
[1] British Med Assoc, London WC1H 9JP, England
关键词
HFEA; IVF; protection; regulation; reproductive autonomy;
D O I
10.1093/humrep/del308
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Parliament will soon be asked to decide about the future regulation of IVF in the United Kingdom. Given that IVF is now considered to be a routine clinical procedure and the fact that we live in an age of unprecedented emphasis on autonomy and patient rights, the justification for continuing to regulate this form of treatment will undoubtedly be challenged. This article considers the four key reasons why the Human Fertilisation and Embryology Authority (HFEA) was originally established-to protect patients and their children, to allay public concerns, to protect scientific freedom and to protect IVF practitioners from claims of unethical behaviour-and asks to what extent these reasons are still valid today. Acknowledging that there are difficulties and frustrations with the HFEA, the article warns that all parties-patients, researchers, IVF practitioners and society-have a lot to lose by limiting the scope of regulation. It concludes that before moving too quickly to get rid of the HFEA as we know it, we need to think carefully about whether the burdens and restrictions imposed by regulation are sufficiently onerous to justify this loss.
引用
收藏
页码:3044 / 3049
页数:6
相关论文
共 50 条
  • [41] WHO BENEFITS FROM COMPUTERS
    GELLES, J
    [J]. COMPUTER DESIGN, 1987, 26 (09): : 20 - 20
  • [42] WHO BENEFITS FROM ECT
    ABRAMS, R
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1992, 161 : 129 - 129
  • [43] Who Benefits from Meritocracy?
    Perez, Santiago
    Moreira, Diana
    [J]. JOURNAL OF ECONOMIC HISTORY, 2022, 82 (02): : 594 - 594
  • [44] Overweight in childhood, intervention versus screening, who benefits?
    Graf, C.
    Koch, B.
    Sreeram, N.
    Brockmeier, K.
    Tokarski, W.
    Dordel, S.
    Predel, H. G.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 659 - 660
  • [45] Blastocyst versus cleavage stage transfers: who benefits?
    Dirican, E. K.
    Olgan, S.
    Caglar, M.
    Sakinci, M.
    Erturk, O.
    Kadir
    Kasabali, Z.
    Cakmakli, U.
    [J]. HUMAN REPRODUCTION, 2020, 35 : 3 - 3
  • [46] Price regulation in the Spanish energy sectors:: who benefits?
    Arocena, P
    Contín, I
    Huerta, E
    [J]. ENERGY POLICY, 2002, 30 (10) : 885 - 895
  • [47] Who Benefits from Aid for Trade? Comparing the Effects on Recipient versus Donor Exports
    Huehne, Philipp
    Meyer, Birgit
    Nunnenkamp, Peter
    [J]. JOURNAL OF DEVELOPMENT STUDIES, 2014, 50 (09): : 1275 - 1288
  • [48] Benefits of immune protection versus immunopathology costs: A synthesis from cytokine KO models
    Sorci, Gabriele
    Lippens, Cedric
    Lechenault, Clothilde
    Faivre, Bruno
    [J]. INFECTION GENETICS AND EVOLUTION, 2017, 54 : 491 - 495
  • [49] Who Benefits From Volunteering? Variations in Perceived Benefits
    Morrow-Howell, Nancy
    Hong, Song-Iee
    Tang, Fengyan
    [J]. GERONTOLOGIST, 2009, 49 (01): : 91 - 102
  • [50] Sustainability, autonomy, and benefits from forest commons Reply
    Chhatre, Ashwini
    Agrawal, Arun
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (14) : E53 - E53